Delivery Order SPE2DB22D2007-SPE2DB25FJ3FZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,011.75 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 1,000 tablets of Losartan Potassium 50 mg. This contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.76 on July 28, 2025, for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of routine pharmaceutical procurement operations supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.45 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This award represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Losartan-HCTZ 100-25 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,095.47. This firm fixed-price delivery order, which is set to be completed by July 23, 2025, represents a single-transaction pharmaceutical procurement from the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no...
- The Defense Logistics Agency awarded a $19,748.97 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90 units. The contract employs firm fixed-price pricing with no set-aside designation and is scheduled for completion by July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,567.77, is for the procurement of 4,564,885,548 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of June 13, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $5,910.20 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90 units. This firm fixed-price delivery order, which is not set-aside designated, is set to complete on July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,907.53 firm fixed-price delivery order is for 1,000 units of Losartan Potassium 100 mg tablets, with a completion date of August 8, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,072.77 firm fixed-price delivery order is for the supply of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of April 21, 2023 and was awarded on April 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- The Defense Logistics Agency awarded a delivery order valued at $18,928.44 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3FZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,084.59 to AmerisourceBergen Drug Corp for the supply of Losartan Potassium 25 mg tablets in quantities of 1,000 units. This order, which was competitively awarded without a set-aside designation, represents a firm fixed-price delivery under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of July 24, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which extends through December 2026. This prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving organizations including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Losartan Potassium, a common antihypertensive medication, exemplifies the ongoing pharmaceutical procurement needs of the federal healthcare system and demonstrates AmerisourceBergen's role as a critical supplier within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/23/25 |